πŸ‡ΊπŸ‡Έ FDA
Patent

US 8193357

Androgen receptor modulator compounds

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8193357 (Androgen receptor modulator compounds) held by Ligand Pharmaceuticals Incorporated expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00